YVYashavantha L. Vishweshwaraiah

Yashavantha L. Vishweshwaraiah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yashavantha L. Vishweshwaraiah has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A noncommutative combinatorial protein logic circuit controls cell orientation in nanoenvironments

    by Jiaxing Chen, Yashavantha L. Vishweshwaraiah, Richard B. Mailman, Erdem D. Tabdanov, Nikolay V. Dokholyan

    Single-protein–based devices that integrate signal sensing with logical operations to generate functional outputs offer exceptional promise for monitoring and modulating biological systems. Engineering such intelligent nanoscale computing agents is challenging, as it requires the integration of sensor domains into a functional protein via intricate allosteric networks. We incorporate a rapamycin-sensitive sensor (uniRapR) and a blue light-responsive LOV2 domain into human Src kinase, creating a protein device that functions as a noncommutative combinatorial logic circuit. In our design, rapamycin activates Src kinase, causing protein localization to focal adhesions, whereas blue light exerts the reverse effect that inactivates Src translocation. Focal adhesion maturation induced by Src activation reduces cell migration dynamics and shifts cell orientation to align along collagen nanolane fibers. Using this protein device, we reversibly control cell orientation by applying the appropriate input signals, a framework that may be useful in tissue engineering and regenerative medicine.


  • Adaptation‐Proof SARS‐CoV‐2 Vaccine Design

    by Yashavantha L. Vishweshwaraiah, Brianna Hnath, Brendan Rackley, Jian Wang, Abhinay Gontu, Morgan Chandler, Kirill A. Afonin, Suresh V. Kuchipudi, Neil Christensen, Neela H. Yennawar, et al.

    Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) surface spike glycoprotein—a major antibody target—is critical for virus entry via engagement of human angiotensin‐converting enzyme 2 (ACE2) receptor. Despite successes with existing vaccines and therapies that primarily target the receptor binding domain (RBD) of the spike protein, the susceptibility of RBD to mutations provides escape routes for the SARS‐CoV‐2 from neutralizing antibodies. On the other hand, structural conservation in the spike protein can be targeted to reduce escape mutations and achieve broad protection. Here, candidate stable immunogens are designed that mimic surface features of selected conserved regions of spike protein through “epitope grafting,” in which the target epitope topology is presented on diverse heterologous scaffolds that can structurally accommodate the spike epitopes. Structural characterization of the epitope‐scaffolds showed stark agreement with computational models and target epitopes. The sera from mice immunized with engineered designs display epitope‐scaffolds and spike binding activity. The utility of the designed epitope‐scaffolds in diagnostic applications is also demonstrated. Taken all together, this study provides an important methodology for targeting the conserved, non‐RBD structural motifs of spike protein for SARS‐CoV‐2 epitope vaccine design and demonstrates the potential utility of “epitope grafting” in rational vaccine design.


  • Faculty Opinions recommendation of Optogenetic manipulation of cellular communication using engineered myosin motors.

    by Nikolay Dokholyan, Yashavantha Vishweshwaraiah

    This article describes optogenetically controlled motor proteins, called ‘artificial transport vehicles’ (ATVs). ATVs consist of multi-headed myosin motors that can move bi-directionally within long cellular extensions, and they can selectively transport green fluorescent protein (GFP)-tagged protein over long distances. The authors tested the ATVs in live cells and neurons using different cargo proteins. The authors were able to control cargo transport with high spatiotemporal resolution and directly manipulate the cellular protrusions in vivo. Overall, the authors have developed an optogenetics-based ATV system for cargo transport by engineering myosin proteins, and these ATVs could be useful in various cell biology studies.

  • Open Access

    Adaptation-proof SARS-CoV-2 vaccine design

    by Yashavantha L. Vishweshwaraiah, Brianna Hnath, Brendan Rackley, Jian Wang, Abhinay Gontu, Morgan Chandler, Kirill A. Afonin, Suresh V. Kuchipudi, Neil Christensen, Neela H. Yennawar, et al.

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) surface spike glycoprotein - a major antibody target - is critical for virus entry via engagement of human angiotensin-converting enzyme 2 (ACE2) receptor. Despite successes with existing vaccines and therapies that primarily target the receptor binding domain (RBD) of the spike protein, the susceptibility of RBD to mutations provides escape routes for the SARS-CoV-2 from neutralizing antibodies. On the other hand, structural conservation in the spike protein can be targeted to reduce escape mutations and achieve broad protection. Here, we designed candidate stable immunogens that mimic surface features of selected conserved regions of spike protein through ‘epitope grafting,’ in which we present the target epitope topology on diverse heterologous scaffolds that can structurally accommodate the spike epitopes. Structural characterization of the epitope-scaffolds showed stark agreement with our computational models and target epitopes. The sera from mice immunized with engineered designs display epitope-scaffolds and spike binding activity. We also demonstrated the utility of the designed epitope-scaffolds in diagnostic applications. Taken all together, our study provides important methodology for targeting the conserved, non-RBD structural motifs of spike protein for SARS-CoV-2 epitope vaccine design and demonstrates the potential utility of ‘epitope grafting’ in rational vaccine design.


  • Faculty Opinions recommendation of Temperature-responsive optogenetic probes of cell signaling.

    by Nikolay Dokholyan, Yashavantha Vishweshwaraiah

    This article describes a single-component optogenetic probe whose activation dynamics depend on light and temperature. Here, the goal was to develop BcLOV4-based optogenetic probes for Ras or PI3K activation. During the process, the authors found out that BcLOV4 acts as a temperature sensor. The authors characterized the designed optogenetic probes, performed some interesting experiments, and came up with a quantitative model to predict the BcLOV4 and downstream signaling dynamics as a function of light and temperature. Using the temperature sensitivity property of BcLOV4, authors have demonstrated the BcLOV4 applicability in multiplexing with blue-light sensitive optogenetic probes in single cells. Overall, authors have developed BcLOV4-based optogenetic probes, which are also temperature sensitive. This newly identified property of BcLOV4 may find usefulness in developing light and temperature-controlled proteins.

  • The enzymatic lectin of field bean (Dolichos lablab): Salt assisted lectin–sugar interaction

    by Devavratha H. Rao, Yashavanth L. Vishweshwaraiah, Lalitha R. Gowda